Objectives: This meta-analysis examines whether there is any advantage of coronary artery bypass graft with bilateral internal thoracic artery (BITA) as an in situ versus composite graft.
Results: Two randomized controlled trials (RCTs; n ¼ 705), 2 matched (n ¼ 1688), and 4 unadjusted observational studies (n ¼ 3517) met inclusion criteria. Composite grafting trended towards greater distal anastomoses (þ0.22, 95% confidence interval, À0.01 to þ0.45 anastomoses/patient; P ¼ .06 [4 unadjusted observational studies]) and greater distal anastomoses using an internal thoracic artery (þ0.80, 95% confidence interval, 0.41-1.18 anastomoses/patient; P <.001 [1 RCT]). There were no differences in perioperative or longer-term composite cardiovascular outcomes comparing in situ versus composite BITA or individual outcomes of mortality, repeat revascularization, myocardial infarction, and cardiovascular mortality. Pooled results differed by study type with pooled results from lower-risk-of-bias RCTs typically showing increases in events rates, and pooled results from higher-risk-of-bias unadjusted observational studies typically showing decreases in event rates of in situ versus composite BITA. Post hoc subgroup analysis suggested possible improvements in all-cause mortality and revascularization for in situ BITA in studies with short-term (<5 years) versus longer-term follow-up, regardless of study type.
Conclusions:
Our meta-analysis found that use of BITA as a composite graft configuration facilitated greater internal thoracic artery revascularization but both grafting strategies offer similar clinical outcomes. Our study supports the use of in situ and composite BITA for select patients but high-quality, long-term prospective trials are needed. (J Thorac Cardiovasc Surg 2017;153:1108-16)
Surgical revascularization with composite versus in situ bilateral internal thoracic artery.
Central Message
In situ and composite bilateral internal thoracic artery configurations provide similar outcomes with respect to major adverse cardiovascular events.
Perspective
Strong data support the use of bilateral internal thoracic artery during coronary artery bypass grafting, but it is unclear whether one configuration is preferred over another. We found similar outcomes with respect to mortality, myocardial infarction, and repeat revascularization with either the in situ or composite bilateral internal thoracic artery configuration.
See Editorial Commentary page 1117.
Contemporary coronary artery bypass graft is still primarily performed by the use of a single internal thoracic artery and vein grafts. The sentinel work by Loop and colleagues 1 showed a survival advantage in favor of the left internal thoracic artery (LITA) to bypass the left anterior descending. In 1999, Lytle and colleagues 2 then reported that 2 internal thoracic arteries (ITAs), or bilateral internal thoracic artery (BITA), was better than one. Numerous publications have since reported excellent long-term patency when using BITA, which has been supported by the American and European guidelines in select patients. [3] [4] [5] [6] [7] [8] [9] The Arterial Revascularisation Trial prospectively randomized 3102 patients to BITA or single internal thoracic artery with a primary outcome of survival at 10 years. 10 When completed, the results of this study will further shape our guidelines regarding the use of BITA.
There exists equipoise regarding the precise BITA grafting strategy. In large series from the Cleveland Clinic and elsewhere, the majority of ITAs were used as in situ grafts, and any free grafts were performed as aortocoronary grafts. [2] [3] [4] 11 In this configuration, there is the benefit of 2 sources of inflow. The other major configuration uses an in situ LITA-left anterior descending with a composite right internal thoracic artery (RITA) anastomosed to the midportion of the LITA and used to graft the lateral wall. [12] [13] [14] This strategy may facilitate anaortic off-pump coronary artery bypass graft but requires balanced run-offs in both coronary targets. The drawback to this configuration is its dependence on a single inflow and the potential risk of steal between the arms of the ITA composite graft and between any sequential anastomotic targets. Here, we performed a systematic review and meta-analysis to determine whether there is a difference between in situ versus composite BITA grafting strategy on graft patency and clinical outcomes.
METHODS

Data Sources
We systematically searched OVID versions of MEDLINE and EM-BASE (1996 through 2016) for all studies using ''bilateral internal mammary artery'' or ''bilateral internal thoracic artery'' or ''right internal mammary artery'' or ''right internal thoracic artery'' in the title or abstract. We also searched bibliographies of included studies.
Study Selection
We included all studies comparing in situ versus composite BITA in patients undergoing coronary artery bypass graft that reported any of the prespecified perioperative or longer-term clinical (ie, all-cause mortality, myocardial infarction [MI], stroke, repeat revascularization, recurrent angina, cardiovascular mortality) or angiographic outcomes (ie, ITA graft occlusion). Studies were excluded if no clinical outcomes were reported or data were published only as an abstract. We excluded studies with any aortocoronary ITA. Citations were screened in duplicate and full-text review, also in duplicate, was performed to determine eligibility when either screening reviewer felt a citation potentially met inclusion criteria. Disagreements regarding inclusion were reconciled via consensus.
Data Extraction and Quality Assessment
Two reviewers independently abstracted data, including details of the publication, inclusion/exclusion criteria, patient demographics and cardiac risk factors, description of the interventions used, and outcome definitions and events. Risk of bias in randomized controlled trial (RCTs; including blinding of participants, method of sequence generation and allocation concealment, intention-to-treat analysis, early trial stopping for efficacy before the planned enrollment was completed, and loss to follow-up) and cohort studies (including retrospective vs prospective data collection, concurrent vs historical controls, and comparable baseline characteristics of cases and controls) were assessed with disagreements resolved by consensus.
Data Analysis
For observational studies that reported both unmatched and propensityscore matched data, we preferentially used the matched data. 15, 16 All analyses were performed with Review Manager (RevMan version 5.2; Cochrane Collaboration, Oxford, United Kingdom). For perioperative outcomes with similar follow-up between groups, log risk ratios were derived for binary outcomes and weighted mean differences (MDs) for continuous outcomes. For long-term outcomes with potentially different follow-up durations between groups, we derived the log incidence and corresponding standard error from numbers of reported events and accumulated person-years of follow-up. If these data are unavailable, we estimated log incidence rate ratios and corresponding standard errors from survival curves and log-rank P values as previously described. [17] [18] [19] Log incidence rate ratios were pooled via the generic inverse variance method (Tables E1 and E2 ). The number of anastomoses were treated as count data and analyzed as rates.
Two sets of observational studies from 2 research groups appeared to have at least partially overlapping patient populations. 15, [20] [21] [22] We attempted to contact the authors but were unable to determine the degree of overlap. For outcomes in which 2 partially overlapping studies both provided results (for some perioperative outcomes among unadjusted observational data), we included only the larger 15, 20 of both pairs of unadjusted observational studies to avoid potentially double counting patients and exaggerating treatment effects. As a sensitivity analysis, we repeated each analysis including both studies from each potentially partially overlapping pair of studies to avoid excluding the nonoverlapping patient data. The sensitivity analysis only significantly changed the pooled analyses in one case (see Results section).
Post hoc subgroup analyses comparing studies with short versus long duration of follow-up, using a threshold of 5 years of follow-up, were conducted for pooled analyses of long-term outcomes.
All analyses used random effects models that incorporate between-trial heterogeneity and give wider, more conservative confidence intervals (CIs) when heterogeneity is present. 23 We assessed statistical heterogeneity among trials using I 2 , defined as the percentage of total variability across studies attributable to heterogeneity rather than chance, and used published suggestions for low (25%), moderate (50%), and high (75%) heterogeneity. 24 Individual trial and pooled summary results are reported with 95% CIs. Differences between pooled results of RCTs versus matched observational studies and versus unadjusted observational studies, and studies with shorter versus longer follow-up durations were evaluated using z tests. We did not publish a review protocol. PRISMA checklist is provided (Tables  E3 and E4). full-text review ( Figure E1 ). One randomized trial published perioperative and short-term outcomes followed by longer-term outcomes in a later publication.
25,26
Description of Included Studies and Patients
There were 2 RCTs (n ¼ 705 patients; 2-7 years followup), 25 ,27 2 propensity score-matched observational studies (n ¼ 1688; 8.7-16.7 years mean follow-up), 15, 16 and 4 unadjusted observational studies (n ¼ 3517; 0.4-3.5 years mean follow-up) [20] [21] [22] 28 that met criteria for inclusion. The randomized trials were unblinded and did not specify whether allocation was concealed, but they used intention-to-treat analysis, were not stopped early for benefit, and had no or low percentage of randomized patients without outcome data (Table E5) . One of the observational studies was prospective 22 and the remaining studies were retrospective; all included a comparison with concurrent controls. In 4 studies, there were differences in baseline characteristics between groups, with the composite group having more comorbidities or more severe coronary disease (Table 1 and Table E6 ) than the in situ group in 3 of these. Overall, the preoperative variables were comparable in both groups for age, sex, and prevalence of diabetes (Table 1) .
Operative Details
Comparing in situ with composite grafting, we found there was a trend to a lower number of distal anastomoses for the unadjusted observational studies (MD, 0.22; 95% CI, 0.01 greater to 0.45 fewer anastomoses/patient, P ¼ .06 [4 studies, 5366 patients]; Table 2, Figure E2 ). Decreases in the RCT and matched observational subgroups were not statistically significant. There were fewer distal anastomoses performed with ITA in the RCTs (MD, 0.80; 95% CI, 0.42-1.18 fewer anastomoses, P <.001) and the unadjusted observational studies (MD, 0.48; 95% CI, 0.33-0.63 fewer anastomoses, P<.001) with in situ grafting ( Figure E3 ). This was reflected in shorter crossclamp times (10 minutes, 95% CI, 5-14 minutes shorter, P<.001) in the unadjusted observational studies, which was not different (4 minutes shorter, 95% CI, 11 minutes shorter to 3 minutes longer; P ¼ .28) in the RCTs (interaction P ¼ .16) ( Figure E4 ) for the in situ group, and shorter cardiopulmonary bypass times (11 minutes, 95% CI, 5-18 minutes shorter, P <.001) in the unadjusted observational studies, and not different (3 minutes shorter, 95% CI, 14 minutes shorter to 8 minutes longer, P ¼ .63) in the RCTs (interaction P ¼ .21) ( Figure E5 ). There was no difference in the proportion of procedures performed off-pump (risk ratio 1.02, 95% CI, 0.73-1.44; P ¼ .89). Most of these analyses exhibited moderate-to-high heterogeneity.
Surgical Outcomes
There were no differences in 30-day mortality ( Figure E6 ), perioperative MI ( Figure E7 ), or perioperative stroke ( Figure E8 ). There was no evidence of heterogeneity in any of the meta-analyses (I 2 ¼ 0%), and there were no subgroup differences in pooled results by study type (ie, all interaction P values comparing pooled results of RCTs to pooled results of either matched observational or unadjusted observational studies were nonsignificant).
Long-Term Outcomes
For the longer-term outcomes including major adverse cardiac event (MACE; long-term mortality, nonfatal MI, and repeat revascularization; Figure 1 ), all-cause mortality (Figure 2 intermediate results)
. No pooled increases (10%-100% for RCT subgroups) or decreases (26%-58% for unadjusted observational study subgroups) in incidence rate ratios, however, achieved statistical significance despite their magnitude, likely as the result of small numbers. This differential effect by study type was particularly evident for MACE, all-cause mortality, and repeat revascularization where interaction P values comparing the pooled results of the RCTs or the pooled results of the matched observational studies to the pooled results of the unadjusted observational studies were .07, .09, and .04, respectively. Post hoc subgroup analyses compared studies with shorter versus longer term follow-up, using a threshold of 5 years, where possible. For all-cause mortality ( Figure E9 , A), the RCT subgroup and the unadjusted observational study subgroup each included studies with less than and more than 5 years of follow-up, whereas for MACE ( Figure E9 , B) only the RCT subgroup and for revascularization ( Figure E9 , C) only the unadjusted observational study subgroup included both lengths of follow-up studies. Each of these comparisons showed a general directional pattern where the difference in adverse events favoring in situ versus composite BITA was more evident in the shorter term follow-up trials, although these differences only approached statistical significance for the unadjusted observational study subgroup comparison for the revascularization outcome (interaction P ¼ .08), whereas for the other comparisons, interaction P ¼ .35-.40. Interestingly, this directional pattern favoring in situ versus composite BITA also was observed comparing trials with shorter versus longer term follow-up within both the matched observational long-term follow-up subgroup, and the unadjusted observation long-term follow-up subgroup, although again these directional differences did not achieve statistical significance.
DISCUSSION
This meta-analysis is the first to compare outcomes of the 2 most common BITA grafting strategies. As suggested by this study, composite grafting was associated with a greater number of distal anastomoses using ITAs. Both strategies were similar with respect to the primary efficacy outcome, including a composite of all-cause death, nonfatal MI, and repeat revascularization or the individual components. This was the case despite the fact that there were more ITA distal anastomoses performed in the composite graft group with no differences in the incidence of ITA occlusion. A possible explanation is the greater comorbidities present in the composite cohort in 2 of the retrospective studies. 20, 28 Higher-risk-of-bias unadjusted observational studies typically showed greater benefit than the lower-risk-of-bias matched observational studies or RCTs for in situ versus composite grafts, which corresponded to the composite group having more comorbidities or more severe coronary disease than the in situ group in most of the unadjusted observational studies. In contrast, lower-risk-of-bias RCTs showed greater rates of adverse outcomes for in situ versus composite grafts, although none of the differences achieved statistical significance. Post hoc subgroup analysis suggests possible improvements in the in situ versus composite grafts in studies with less than 5 years of follow-up compared with studies with longer follow-up, but these results need to be interpreted cautiously as none of these differences, although consistent across study types and across outcomes, achieved statistical significance.
A potential drawback of the composite BITA technique is the reliance on a single inflow for multiple outflows and the risk of steal between the 2 arms of the composite graft as well as between sequential anastomoses. Several groups have shown a greater incidence of nonoptimal graft flows and graft failure with arterial composite and sequential grafting. [29] [30] [31] [32] Neragi-Miandoab and colleagues 29 performed 28 Hwang and colleagues, 15 Lev-Ran and colleagues, 21 and Di Mauro and colleagues. 16 Cerebrovascular events were also included for Glineur and colleagues 15 (ie, MACCE). Angina and all coronary artery occlusions also were included for Nasso and colleagues. 27 Individual study and pooled incidence rate ratios for composite cardiovascular outcome in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled incidence rate ratios with 95% CI were calculated by the use of random-effects models. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. Comparing the pooled result of the unadjusted observational studies to the pooled result of the RCTs (ie, the 2 subgroups with the most disparate pooled results) yields an interaction P ¼ . Forest plot for repeat revascularization. Individual study and pooled incidence rate ratios for repeat revascularization in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled incidence rate ratios with 95% CI were calculated by the use of random-effects models. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. Comparing the pooled result of the unadjusted observational studies to the pooled result of the RCTs yields an interaction P ¼ .04, and comparing the pooled result of the matched observational studies to the pooled result of the RCTs yields an interaction P ¼ .05. Mean incidence rate for revascularization ranged from 0.2% to 1.6%/year among included studies. SE, Standard error; CI, confidence interval; RCT, randomized controlled trial.
FIGURE 2.
Forest plot for all-cause mortality. Individual study and pooled incidence rate ratios for all-cause mortality in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled incidence rate ratios with 95% CI were calculated by the use of random-effects models. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. Comparing the pooled result of the unadjusted observational studies to the pooled result of the RCTs yields an interaction P ¼ .22, and to the pooled result of the matched observational studies, an interaction P ¼ .09.
Mean incidence rate for all-cause mortality ranged from 1.4% to 3.4%/year among included studies. SE, Standard error; CI, confidence interval; RCT, randomized controlled trial.
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The Journal of Thoracic and Cardiovascular Surgery c Volume 153, Number 5 1113 ACQ Nakajima and colleagues 31 report greater antegrade flow for in situ LITA with RITA I-graft compared with LITA-RITA Y-grafts (92.5% vs 89.7%, P ¼ .049). In this study, the authors cleverly decide on the orientation of the I-graft (inferior wall to lateral wall or vice versa) to ensure that the most distal target has the greater anticipated flow. Thus, these authors suggest that the Y-graft may be more prone to competitive flow than a composite I graft constructed FIGURE 5 . Forest plot of cardiovascular mortality. Individual study and pooled incidence rate ratios for cardiovascular mortality in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled incidence rate ratios with 95% CIs were calculated by the use of random-effects models. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. The pooled result of the matched observational studies is not statistically different to the pooled result of the unadjusted observational studies (interaction P ¼ .39). Mean incidence rate for cardiovascular mortality ranged from 0.5% to 1.3%/year among included studies. SE, Standard error; CI, confidence interval; RCT, randomized controlled trial. . Forest plot for myocardial infarction. Individual study and pooled incidence rate ratios for myocardial infarction in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled incident rate ratios with 95% CI were calculated by the use of random-effects models. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. The pooled result of the RCTs is similar to the pooled result of the unadjusted observational studies (interaction P ¼ .58). Mean incidence rate for myocardial infarction ranged from 0.1% to 1.1%/year among included studies. SE, Standard error; CI, confidence interval; RCT, randomized controlled trial.
with ITA conduits, and that this competitive flow may beget graft failure. Sakaguchi and colleagues 32 demonstrated less coronary flow reserve in composite grafts. Taken together, composite grafting requires greater consideration of the native coronary anatomy including degree of proximal stenosis and size of coronary perfusion bed. In some cases, composite grafting may lack driving pressure and may be at risk of competitive flow and graft failure; however, we did not show any differences in ITA patency and composite grafting does allow for greater ITA revascularization. Thus, overall we found no clear benefit of one grafting strategy over another.
We report no difference in incidence of stroke in the 2 cohorts. In our report, 2 studies were performed off-pump 15, 22 and 6 primarily on-pump. 16, 20, 21, [25] [26] [27] [28] It is likely that a noaortic touch off-pump coronary artery bypass graft surgical revascularization will reduce the perioperative risk of stroke as suggested by previous studies and supported by a recent consensus statement but this could not be assessed here.
33-35
Study Strengths and Limitations
This is the first systematic review and meta-analysis to compare in situ versus composite BITA grafting. The strength of this review is the use of rigorous methodology, including a reproducible and comprehensive literature search, clearly defined inclusion criteria, and duplicate citation review, data abstraction, and quality assessment of individual studies. Our systematic review highlights the small number of studies and small numbers of enrolled patients per study, with only a minority of these originating from randomized controlled trials.
Consequently, it is difficult to arrive at definitive conclusions from the limited data. In particular, data from observational studies should be interpreted with caution as even in the matched cohorts, there is likely a high degree of selection bias in allocating patients to either technique. It is likely that not all patients in each of the observational studies would even be eligible for both approaches, and within each study it is unclear how closely outcomes are related to operator rather than technique. The 2 publications by Lev-Ran and colleagues, 20, 21 as well as 2 other publications from another research group, 15, 22 may have some overlapping patients. As mentioned, for the few perioperative outcomes where data were available for potentially overlapping studies, all primary analyses included only the larger study by Lev-Ran and colleagues 20 and the matched study from the other research group 15 to avoid double counting some patients and potentially exaggerating treatment effects. However, this risks excluding nonoverlapping patients between the pairs of studies so in sensitivity analyses we repeated each analysis including both studies from each pair, which did not significantly change any of the analyses except for the total distal anastomoses pooled result which only became statistically significant when all studies were included. Finally, the composite grafts were composed of either T- 27, 28 or Y-grafts 15, 16, [20] [21] [22] 25, 26 in different studies. Given that both were associated with excellent outcomes, however, any hemodynamic difference is unlikely to be significant.
CONCLUSIONS
Composite grafting requires a balanced run-off in grafted territories but allows a greater number of distal anastomoses using ITA. We found similar outcomes with respect to mortality, MI, and repeat revascularization with in situ and composite BITA. Thus, our findings support the continued use and evaluation of BITA in both configurations. The lack of comparative data suggests the need for high-quality and long-term prospective trials focused on the optimal form of arterial revascularization.
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We are grateful to Dr David Glineur for kindly providing the number of patients with myocardial infarctions and the number with only strokes/cerebrovascular events (which allowed calculation of major adverse cardiac event rates rather than the published major adverse cardiac and cerebrovascular event rates) over the 7 years of follow-up for his RCT. 25 We also thank Dr George A. Tomlinson (Division of Biostatistics, Department of Medicine, University of Toronto) for statistical review. FIGURE E2. Forest plot for total distal anastomoses. Individual study and pooled mean differences in total distal anastomoses in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled mean differences with 95% CI were calculated by the use of random-effects models. There were no differences between the pooled result of the RCTs versus the pooled result of the matched observational studies versus the pooled result of the unadjusted observational studies (pairwise comparison interaction P ¼ .36-.75). Only the 2002 paper by Lev-Ran and colleagues 20 and not the 2004 paper by Lev-Ran and colleagues, 21 and only Hwang and colleagues 15 but not Kang and colleagues 22 were included in the pooled analysis to avoid duplicate counting of some patients, given likely partial overlapping patient populations in these FIGURE E3. Forest plot for ITA distal anastomoses. Individual study and pooled MD for total distal anastomoses in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled mean differences with 95% CI were calculated by the use of random-effects models. As shown in the figure, both the RCT and unadjusted observational study subgroups demonstrated statistically significant decreases in ITA distal anastomoses for in situ versus composite BITA, although the decrease in the RCT subgroup was larger but not statistically different (interaction P ¼ .12). Pooled results were different compared with the matched observational subgroup for both the RCT (interaction P ¼ .005) and unadjusted observational (interaction P ¼ .04) subgroups. Only Hwang and colleagues 15 and not Kang and colleagues 22 was included in the pooled analysis of the unadjusted observational subgroup to avoid duplicate counting of some patients, given likely partial overlapping patient populations in this pair of studies. If data from both of these studies are included, the pooled decrease in the number of ITA distal anastomoses in the unadjusted observational subgroup is not significantly changed (MD, À0.47; 95% CI, À0.61 to À0.32 anastomoses/patient, P < .00001, I 2 ¼ 0%). SE, Standard error; CI, confidence interval; RCT, randomized controlled trial.
FIGURE E4. Forest plot of crossclamp time. Individual study and pooled MD for crossclamp time in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled mean differences with 95% CI were calculated by the use of random-effects models. For Glineur and colleagues, 26 standard deviations were estimated based on reported means and P values. As shown in the figure, the decreases in crossclamp time for in situ versus composite BITA between the RCT and unadjusted observational study subgroups were similar (interaction P ¼ .16) but only the decrease in the unadjusted observational study subgroup was statistically significant (P <.0001). Only the 2002 paper of Lev-Ran and colleagues 20 and not the 2004 paper of Lev-Ran and colleagues 21 was included in the pooled analysis of the unadjusted observational subgroup to avoid duplicate counting of some patients, given likely partial overlapping patient populations in this pair of studies. If data from both of these studies are included, the pooled decrease in the crossclamp time in the unadjusted observational subgroup is not significantly changed (MD, À8.26; 95% CI, À11.84 to À4.68 minutes, P <.00001, I 2 ¼ 69%). SD, Standard deviation; CI, confidence interval; RCT, randomized controlled trial.
FIGURE E5. Forest plot of cardiopulmonary bypass time. Individual study and pooled MD for coronary pulmonary bypass time in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled mean differences with 95% CI were calculated by the use of random-effects models. For Glineur and colleagues, 26 standard deviations were estimated based on reported means and P values. As shown in the figure, the decreases in crossclamp time for in situ versus composite BITA between the RCT and unadjusted observational study subgroups were similar (interaction P ¼ .21) but only decrease in the unadjusted observational study subgroup was statistically significant (P ¼ .0008).
Only the 2002 paper of Lev-Ran and colleagues 20 and not the 2004 paper of Lev-Ran and colleagues 21 was included in the pooled analysis of the unadjusted observational subgroup to avoid duplicate counting of some patients, given likely partial overlapping patient populations in this pair of studies. If data from both of these studies are included, the pooled decrease in the crossclamp time in the unadjusted observational subgroup is not significantly changed (MD, À8.05; 95% CI, À15.30 to À0.80 minutes, P ¼ .03, I 2 ¼ 80%). SD, Standard deviation; CI, confidence interval; RCT, randomized controlled trial.
FIGURE E6
. Forest plot for 30-day mortality. Individual study and pooled RRs for 30-day mortality in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled RRs with 95% CI were calculated by the use of random-effects models. There were no differences between the pooled result of the RCTs versus the pooled result of the matched observational studies versus the pooled result of the unadjusted observational studies (pairwise comparison interaction P ¼ .27-.86). Only the 2002 paper of Lev-Ran and colleagues 20 and not the 2004 paper of Lev-Ran and colleagues 21 was included in the pooled analysis to avoid duplicate counting of some patients, given likely partial overlapping patient populations in these 2 studies. Including data from both these studies results in minimal changes to the pooled result for the unadjusted observational studies (RR, 0.78; 95% CI, 0.49-1.24, P ¼ .29, I 2 ¼ 0%). Mean overall incidence rate for 30-day mortality was 2.2%.
CI, Confidence interval; RCT, randomized controlled trial.
FIGURE E7. Forest plot for perioperative MI. Individual study and pooled RRs for perioperative MI in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled RRs with 95% CI were calculated by the use of random-effects models. There were no differences between the pooled result of the RCTs versus the pooled result of the matched observational studies versus the pooled result of the unadjusted observational studies (pairwise comparison interaction P ¼ .24-.64). Only the 2002 paper of Lev-Ran and colleagues 20 and not the 2004 paper of Lev-Ran and colleagues 21 was included in the pooled analysis to avoid duplicate counting of some patients, given likely partial overlapping patient populations in these studies. Including data from both these studies results in no significant changes to the pooled result for the unadjusted observational studies (RR, 1.06; 95% CI, 0.53-2.13, P ¼ .86, I 2 ¼ 0%). Mean overall incidence rate for perioperative MI was 1.5%. CI, Confidence interval; RCT, randomized controlled trial.
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The Journal of Thoracic and Cardiovascular Surgery c Volume 153, Number 5 1116.e7 ACQ FIGURE E8. Forest plot for perioperative stroke. Individual study and pooled RRs for perioperative stroke in RCTs versus matched observational studies versus unadjusted observational studies comparing patients with in situ versus composite BITA. The pooled RRs with 95% CI were calculated by the use of random-effects models. There were no differences between the pooled result of the RCTs versus the pooled result of the unadjusted observational studies (interaction P ¼ .78). Only the 2002 paper of Lev-Ran and colleagues 20 and not the 2004 paper of Lev-Ran and colleagues, 21 and only Hwang and colleagues 15 and not Kang and colleagues 22 were included in the pooled analysis to avoid duplicate counting of some patients, given likely partial overlapping patient populations in these 2 pairs of studies. Including data from both pairs of these studies results in no significant changes to the pooled result of the unadjusted observational studies: RR, 0.90; 95% CI, 0.50-1.63, P ¼ .74, I 2 ¼ 0%. Mean overall incidence rate for perioperative stroke was 1.3%. CI, Confidence interval; RCT, randomized controlled trial.
FIGURE E9. Forest plot for (A) all-cause mortality, (B) MACE, and (C) repeat revascularization by duration of follow-up. Individual study and pooled incidence rate ratios comparing studies with shorter versus longer term follow-up using a threshold of 5 years separately for RCTs, matched observational studies and unadjusted observational studies comparing patients with in situ versus composite BITA. The time point that Kaplan-Meier survival curve outcome event estimates, or mean follow-up when absolute outcome events were reported in each study are shown in brackets after author name. The pooled incident rate ratios with 95% CIs were calculated using random-effects models. The lower mortality (A) incident rate ratio in the shorter follow-up study was not statistically different than the incident rate ratio in the longer follow-up study for both the RCTs (interaction P ¼ .38) and unadjusted observational studies (interaction P ¼ .35). The lower MACE (B) incident rate ratio in the shorter follow-up study was not statistically different than the incident rate ratio in the longer follow-up study for the RCTs (interaction P ¼ .40). Comparing the lower revascularization (C) incident rate ratio of in situ versus composite BITA in the shorter follow-up study to the incident rate ratio in the longer follow-up studies yields an interaction P ¼ .08 for the unadjusted observational studies. SE, Standard error; CI, confidence interval; RCT, randomized controlled trial. Study selection 9 State the process for selecting studies (ie, screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).
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Data collection process 10 Describe method of data extraction from reports (eg, piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.
Data items 11
List and define all variables for which data were sought (eg, PICOS, funding sources) and any assumptions and simplifications made.
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Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. 2 ) for each meta-analysis.
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PICOS, Participants, interventions, comparisons, outcomes, and study design. 
2-3
Additional analyses 16 Describe methods of additional analyses (eg, sensitivity or subgroup analyses, metaregression), if done, indicating which were pre-specified.
RESULTS
Study selection
17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.
3 and Figure E1 Study characteristics 18 For each study, present characteristics for which data were extracted (eg, study size, PICOS, follow-up period) and provide the citations.
3 Tables 1 and 2 Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).
3, Tables 3 and 4 Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
